ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Capitol Hill: Senators Reintroduce Breast Cancer Stamp.

January 28, 2005

NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute.

October 12, 2007

Funding Opportunities

April 26, 2002

Program Announcement On Effects Of Low Dose Radiation

October 2, 1981

Program Announcement In Preventative Oncology

May 21, 1982

NCI Tightens Monitoring, Upgrades Staff Training In Attempts To Improve Management Of Contracts

January 9, 1981